Moreover, we defined how compounds 1 and 2 affect the replication of influenza virus, demonstrating that the anti-influenza activity of compounds 1 and 2 is attributable to the inhibition of the PI3K-Akt signaling pathway. The gene discussed is AKT1; the disease is influenza.